نتائج البحث - "Wenham R. M."

1

تقرير

ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA(sic)-nonmutated advanced epithelial ovarian cancer

المؤلفون: Madry, R., Fujiwara, K., Vergote, I. B., Sehouli, J., Salutari, V., Zola, P., Wenham, R. M., Korach, J., Pautier, P., Cibula, D., Lheureux, S., Hasegawa, K., Kim, B-G., Lai, C-H., Gonzalez-Martinez, A., Liu, Q., Keefe, S. M., Puglisi, M., TOPUZ, Samet

المساهمون: Saitama Medical School ,, 3387600

مصطلحات موضوعية: Health Sciences, Oncology, ONKOLOJİ, Klinik Tıp, Klinik Tıp (MED), Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji

العلاقة: Fujiwara K., Vergote I. B. , Sehouli J., Salutari V., Zola P., Madry R., Wenham R. M. , Korach J., Pautier P., Cibula D., et al., "ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA(sic)-nonmutated advanced epithelial ovarian cancer", European-Society-for-Medical-Oncology (ESMO) Asia Congress, Singapore, Singapur, 22 - 24 Kasım 2019, cilt.30; av_868a78fc-884c-45c8-9d78-047ab3dc2377; vv_1032021; http://hdl.handle.net/20.500.12627/178802Test; 30

الإتاحة: https://doi.org/20.500.12627/178802Test
https://hdl.handle.net/20.500.12627/178802Test

View record in BASE

2

دورية أكاديمية

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

المؤلفون: Brana, I, Berger, R, Golan, T, Haluska, P, Edenfield, J, Fiorica, J, Stephenson, J, Martin, L P, Westin, S, Hanjani, P, Jones, M B, Almhanna, K, Wenham, R M, Sullivan, D M, Dalton, W S, Gunchenko, A, Cheng, J D, Siu, L L, Gray, J E

المصدر: British Journal of Cancer ; volume 111, issue 10, page 1932-1944 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/bjc.2014.497Test
http://www.nature.com/articles/bjc2014497.pdfTest
http://www.nature.com/articles/bjc2014497Test

View record in BASE

3

دورية أكاديمية

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival

المؤلفون: Bicaku, E, Xiong, Y, Marchion, D C, Chon, H S, Stickles, X B, Chen, N, Judson, P L, Hakam, A, Gonzalez-Bosquet, J, Wenham, R M, Apte, S M, Fulp, W, Cubitt, C L, Chen, D-T, Lancaster, J M

المصدر: British Journal of Cancer ; volume 106, issue 12, page 1967-1975 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/bjc.2012.207Test
http://www.nature.com/articles/bjc2012207.pdfTest
http://www.nature.com/articles/bjc2012207Test

View record in BASE

4

مؤتمر

A time without symptoms or toxicity analysis of niraparib compared with routine surveillance in the maintenance treatment of patients with recurrent ovarian cancer

المؤلفون: Mirza, M. R., Walder, L, Monk, B. J., Tinker, A V, Mahner, S, Gil-Martin, M, Kalbacher, E, Waters, J, Wenham, R M, Malander, S, Gilbert, L, Sehouli, J, Casado Herraez, A, Hardy-Bessard, AC, Williams, SJ, Rimel, BJ, Lund, Bente, Levy, T, Guy, H, Matulonis, U. A.

المصدر: Mirza , M R , Walder , L , Monk , B J , Tinker , A V , Mahner , S , Gil-Martin , M , Kalbacher , E , Waters , J , Wenham , R M , Malander , S , Gilbert , L , Sehouli , J , Casado Herraez , A , Hardy-Bessard , AC , Williams , SJ , Rimel , BJ , Lund , B , Levy , T , Guy , H & Matulonis , U A 2018 , ' A time without symptoms or toxicity analysis of niraparib compared with ....

الإتاحة: https://vbn.aau.dk/da/publications/b28c4f83-898d-4282-befe-999ad220cb9aTest
https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84927Test

View record in BASE

5

دورية أكاديمية

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

المؤلفون: Vergote I., Scambia G., O'Malley D. M., Van Calster B., Park S. -Y., del Campo J. M., Meier W., Bamias A., Colombo N., Wenham R. M., Covens A., Marth C., Raza Mirza M., Kroep J. R., Ma H., Pickett C. A., Monk B. J., Park S. Y., Song Y. S., Makarova Y., Trinidad J., Ngan H. Y. S., Aravantinos G., Nam J. -H., Gorbunova V., Krikunova L., Bae D. -S., Arija J. A. A., Mirza M. R., Zamagni C., Papandreou C., Raspagliesi F., Lisyanskaya A., Benzaquen A. O., Tognon G., Ortega E., Herraez A. C., Buscema J., Green A., Burger R., Sakaeva D., Sanchez A. R., Ghamande S., King L., Petru E., Peen U., Takeuchi S., Ushijima K., Martin A. G., Kamelle S., Carney M., Forget F., Bentley J., Sehouli J., Zola P., Kato H., Fadeeva N., Gotovkin E., Vladimirov V., Marin M. R., Alia E. G., Shahin M., Bhoola S., Tewari K., Anderson D., Honhon B., Pelgrims J. G., Oza A., Jimenez J. G. -D., Hansen V., O'Malley D., Benjamin I., Renard V., Van den Bulck H., Haenle C., Koumakis G., Yokota H., Popov V., Bradley W., Wenham R., Reid R., McNamara D., Friedman R., Barlin J., Spirtos N., Chapman J., Sevelda P., Huizing M., Lamot C., Goffin F., Hondt L. D., Spadafora S., Rautenberg B., Reimer T., Mobus V., Hilpert F., Gropp-Meier M., Savarese A., Pignata S., Verderame F., Mizuno M., Takano H., Ottevanger P., Velasco A. P., Palacio-Vazquez I., Law A., McIntyre K., Teneriello M., Fields A., Lentz S., Street D., Schwartz B., Mannel R., Lim P., Pulaski H., Janni W., Zorr A., Karck U., Cheng A. C. K., Sorio R., Gridelli C., Aoki D., Oishi T., Hirashima Y., Boere I., Ferrer E. F., Braly P., Wilks S., Lee C., Schilder J., Veljovich D., Secord A., Davis K., Rojas-Espaillat L., Lele S., DePasquale S., Squatrito R., Schauer C., Dirix L., Vuylsteke P., Joosens E., Provencher D., Lueck H. -J., Hein A., Burges A., Canzler U., Park-Simon T. -W., Griesinger F., Gadducci A., Alabiso O., Okamoto A., Sawasaki T., Saito T., Ibanez A. H., Calomeni C., Spillman M., Choksi J., Taylor N., Muller C., Moore D., DiSilvestro P., Cunningham M., Rose P., Oppelt P., Verhoeven D., Graas M. -P., Ghatage P., Tonkin K., Kurzeder C., Schnappauf B., Muller V., Schmalzrie H., Kalofonos H., Bruzzone M., Kroep J., Diaz C. C., Garcia J. M., Polo S. H., Garrison M., Rocconi R., Andrews S., Bristow R., McHale M., Basil J., Houck III W., Bell M., Cosin J., Modesitt S., Kendrick J., Wade III J., Wong C., Evans A., Buekers T., Vanderkwaak T., Ferriss J., Darus C., DAndre S., Higgins R., Monk B., Bakkum-Gamez J., DeMars L., Van Le L., Puls L., Trehan S., LaPolla J., Michelson E. D., Merchant J., Peterson C., Reid G., Seago D., Zweizig S., Gajewski W., Panwalkar A., Leikermoser R., Bogner G., Debruyne P., D'hondt R., Berteloot P., Kerger J., Biagi J., Castonguay V., Welch S., Muhic A., Heubner M., Grischke E. -M., Rack B., Fleisch M., Lordick F., Pectasides D., Ho W. M., Selvaggi L., Vasquez F. M., Villanueva W. O. B., Alavez A. M., Kessels L., Bertran A. S., Fernandez C. M., Fabregat M. B., Del Prete S., Elkas J., Cecchi G., Kumar P., Huh W., Messing M., Karimi M., Kelley A., Edraki B., Mutch D., Leiserowitz G., Anderson J., Chambers S., Morris R., Waggoner S., Gordon A., Method M., Johnson P., Lord R., Drake J., Sivarajan K., Midathada M., Rice K., Wadsworth T., Pavelka J., Edwards R., Miller D. S., Ford P. L., Hurteau J., Bender D., Schimp V., Creasman W., Lerner R., Chamberlain D., Kueck A., McDonald J., Malad S., Robinson-Bennett B., Davidson S., Krivak T., Lestingi T., Arango H., Berard P., Finkelstein K., Gaur R., Krasner C., Ueland F., Talmage L., Yamada S., Sutton G., Potkul R., Prasad-Hayes M., Osborne J., Celano P., Thigpen J., Sharma S., Schilder R., Tammela J., Kemeny M., Brown A., Eisenhauer E., Williams J., Rowland K., Nahum K., Burke J., Dar Z., Fleming N., Gibb R., Guirguis A., Herzog T., John V., Kumar S., Kamat A., Kassar M., Leitao M., Levine L., Mendez L., Patel D., Berry E., Warshal D., Wolf J., Zarwan C., Collins Y., Spitzer G., Miller B., Einstein M.

المساهمون: Vergote I., Scambia G., O'Malley D.M., Van Calster B., Park S.-Y., del Campo J.M., Meier W., Bamias A., Colombo N., Wenham R.M., Covens A., Marth C., Raza Mirza M., Kroep J.R., Ma H., Pickett C.A., Monk B.J., Park S.Y., Song Y.S., Makarova Y., Trinidad J., Ngan H.Y.S., Aravantinos G., Nam J.-H., Gorbunova V., Krikunova L., Bae D.-S., Arija J.A.A., Mirza M.R., Zamagni C., Papandreou C., Raspagliesi F., Lisyanskaya A., Benzaquen A.O., Tognon G., Ortega E., Herraez A.C., Buscema J., Green A., Burger R., Sakaeva D., Sanchez A.R., Ghamande S., King L., Petru E., Peen U., Takeuchi S., Ushijima K., Martin A.G., Kamelle S., Carney M., Forget F., Bentley J., Sehouli J., Zola P., Kato H., Fadeeva N., Gotovkin E., Vladimirov V., Marin M.R., Alia E.G., Shahin M., Bhoola S., Tewari K., Anderson D., Honhon B., Pelgrims J.G., Oza A., Jimenez J.G.-D., Hansen V., O'Malley D., Benjamin I., Renard V., Van den Bulck H., Haenle C., Koumakis G., Yokota H., Popov V., Bradley W., Wenham R., Reid R., McNamara D., Friedman R., Barlin J., Spirtos N., Chapman J., Sevelda P., Huizing M., Lamot C., Goffin F., Hondt L.D., Spadafora S., Rautenberg B., Reimer T., Mobus V., Hilpert F., Gropp-Meier M., Savarese A., Pignata S.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31076365; info:eu-repo/semantics/altIdentifier/wos/WOS:000469336000054; volume:20; issue:6; firstpage:862; lastpage:876; numberofpages:15; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/2318/1730319Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85066276936; http://www.journals.elsevier.com/the-lancet-oncologyTest/

الإتاحة: https://doi.org/10.1016/S1470-2045Test(19)30178-0
http://hdl.handle.net/2318/1730319Test
http://www.journals.elsevier.com/the-lancet-oncologyTest/

View record in BASE